A bipartisan group of U.S. congressional lawmakers introduced a bill Wednesday to accelerate medical cannabis research, a step that could potentially bolster support for federal marijuana reform.
“Forty-seven states have legalized some form of cannabis, yet the federal government is still getting in the way of further progress on the potential for research,” said Rep. Earl Blumenauer, an Oregon Democrat and co-sponsor of the Medical Marijuana Research Act of 2019.
Currently, the only marijuana available for legal research comes from a contract the National Institute on Drug Abuse holds with the University of Mississippi.
The U.S. Drug Enforcement Administration (DEA) created an application process for growers but has dragged its heels on acting on more than two dozen applications.
The bill, according to sponsors, would:
- Create a new, less cumbersome registration process for marijuana research, reducing approval times, costly security measures and unnecessary layers of protocol review.
- Make it easier for approved researchers to obtain the cannabis they need for their studies by reforming production and distribution regulations.
- Allow for the private manufacturing and distribution of cannabis solely for research purposes.
Douglas Berman, director of Ohio State University’s Drug Enforcement and Policy Center, told Marijuana Business Daily that a niche bill such as the MMJ research proposal generally has a better chance for approval than a more sweeping cannabis reform measure.
The bill already has the support of groups such as Smart Approaches for Marijuana, the Marijuana Policy Project, the American Psychological Association and the American Academy of Neurology.
A bipartisan group of U.S. Senators also recently introduced a bill to bolster CBD and marijuana research. That measure has the backing of the American Medical Association.
Jeff Smith can be reached at [email protected]